NeoGenomics Q3 2025 Earnings Preview

* NeoGenomics (NASDAQ:NEO [https://seekingalpha.com/symbol/NEO]) is scheduled to announce Q3 earnings results on Tuesday, October 28th, before market open.
* The consensus EPS Estimate is $0.02 [https://seekingalpha.com/symbol/NEO/earnings/estimates] (-60.0% Y/Y) and the consensus Revenue Estimate is $183.85M (+9.6% Y/Y).
* Over the last 2 years, NEO has beaten EPS estimates [https://seekingalpha.com/symbol/NEO/earnings/eps-surprise-summary] 100% of the time and has beaten revenue estimates 63% of the time.
* Over the last 3 months, EPS estimates have seen 0 upward revisions [https://seekingalpha.com/symbol/NEO/earnings/revisions] and 12 downward. Revenue estimates have seen 0 upward revisions and 13 downward.

MORE ON NEOGENOMICS

* NeoGenomics, Inc. (NEO) Q2 2025 Earnings Call Transcript [https://seekingalpha.com/article/4805739-neogenomics-inc-neo-q2-2025-earnings-call-transcript]
* NeoGenomics rallies after court win in Natera patent dispute [https://seekingalpha.com/news/4490420-neogenomics-stock-up-court-win-natera]
* NeoGenomics outlines revised 2025 outlook with 9%-10% revenue growth target amid pharma headwinds and PanTracer launch [https://seekingalpha.com/news/4473886-neogenomics-outlines-revised-2025-outlook-with-9-percentminus-10-percent-revenue-growth]
* Seeking Alpha’s Quant Rating on NeoGenomics [https://seekingalpha.com/symbol/NEO/ratings/quant-ratings]
* Historical earnings data for NeoGenomics [https://seekingalpha.com/symbol/NEO/earnings]